Who
David P. Luci
President and CEO
Company insider
Files Form 4 as: President and CEO, Acurx Pharmaceuticals; Director, Enveric Biosciences; President, CEO, Secretary, PLx Pharma; Director, Abeona Therapeutics; Pres. & Chief Business Officer, Macrochem; EVP & General Counsel, Bioenvision.
In numbers
- Trades disclosed
- 45
- Buys
- 5
- Sells
- 2
- Bought
- $177K
- Sold
- $1.6M
- Companies
- 6
- Companies where not an officer
- 2
- First trade
- 6 Jan 2006
- Last trade
- 20 Apr 2026
- Last filed
- 22 Apr 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 20 Apr 2026filed 22 Apr 2026 | ACXP Acurx Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —37,100 at $0.00 | filing |
| 20 Apr 2026filed 22 Apr 2026 | ACXP Acurx Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —37,100 at $0.00 | filing |
| 5 Feb 2025filed 6 Feb 2025 | ACXP Acurx Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —250,000 at $0.00 | filing |
| 6 Jan 2025filed 8 Jan 2025 | ACXP Acurx Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code P | —49,261 at $0.00 | filing |
| 6 Jan 2025filed 8 Jan 2025 | ACXP Acurx PharmaceuticalsBiotechnology | SEC FORM 4 Bought | $50K49,261 at $1.02 | filing |
| 23 Feb 2024filed 3 Apr 2024 | ACXP Acurx Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —250,000 at $0.00 | filing |
| 3 Jan 2024filed 4 Jan 2024 | ACXP Acurx Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —19,737 at $0.00 | filing |
| 3 Jan 2024filed 4 Jan 2024 | ACXP Acurx PharmaceuticalsBiotechnology | SEC FORM 4 Code M | $70K19,737 at $3.55 | filing |
| 13 Feb 2023filed 24 Feb 2023 | ACXP Acurx Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —130,000 at $0.00 | filing |
| 27 Jul 2022filed 29 Jul 2022 | ACXP Acurx Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code P | —19,737 at $0.00 | filing |
| 27 Jul 2022filed 29 Jul 2022 | ACXP Acurx Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code P | —19,737 at $0.00 | filing |
| 27 Jul 2022filed 29 Jul 2022 | ACXP Acurx PharmaceuticalsBiotechnology | SEC FORM 4 Bought | $75K19,737 at $3.80 | filing |
| 19 Nov 2021filed 22 Nov 2021 | ACXP Acurx PharmaceuticalsBiotechnology | SEC FORM 4 Bought | $25K5,200 at $4.80 | filing |
| 1 Jul 2021filed 6 Jul 2021 | ACXP Acurx Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —500,000 at $0.00 | filing |
| 29 Jun 2021filed 6 Jul 2021 | ACXP Acurx Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —350,000 at $0.00 | filing |
| 20 Aug 2018filed 22 Aug 2018 | ENVB Enveric Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —150,000 at $0.00 | filing |
| 20 Aug 2018filed 22 Aug 2018 | ENVB Enveric Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 19 Apr 2017filed 21 Apr 2017 | PLx Pharmaoption or derivative | SEC FORM 4 Code D | —298,826 at $0.00 | filing |
| 17 Jan 2017filed 21 Apr 2017 | PLx Pharmaoption or derivative | SEC FORM 4 Code A | —275,000 at $0.00 | filing |
| 19 Jan 2016filed 21 Jan 2016 | Dipexium Pharmaceuticalsoption or derivative | SEC FORM 4 Code A | $356K35,000 at $10.16 | filing |
News
Acurx Pharmaceuticals (NASDAQ:ACXP) Shares Climb 0.9% – Should You Buy?ACXP · dailypolitical.com · 22 Oct 2026
0 headlines in the last 90 days name David P. Luci; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.